[1]
N. Binello et al., “Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus”, EJCRIM, vol. 5, no. 9, Aug. 2018, doi: 10.12890/2018_000934.